ORPHA:70596
Congenital Epstein-Barr virus infection
Also known as: Antenatal EBV infection · Antenatal Epstein-Barr virus infection · Congenital EBV infection · Mother-to-child transmission of Epstein-Barr virus infection
Publications
8
21.1th percentile
Trials
0
Interventional, condition-specific
Researchers
53
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
A rare infectious disease that causes no clinical manifestations in the majority of infants. Indeed, the occurrence of infection with EBV has never been demonstrated conclusively and must be very rare. One case has been reported to present after birth, multiple anomalies (micrognathia, cryptorchidism, central cataracts), , generalized , , diffuse petechiae and hematomas and multiple areas of metaphysitis of the long bones at birth. A low birth weight was also reported. No specific follow-up of the fetus is recommended following maternal EBV primary-infection.
How rare: How common this is has not been clearly measured.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0019094
- UMLS:C4274357
Additional Mondo synonyms (4)
antenatal EBV infection · antenatal Epstein-Barr virus infection · congenital EBV infection · mother-to-child transmission of Epstein-Barr virus infection
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
8 matched papers (5 in last 10 years) Source
- Phenotype characterisedNot found
No HPO disease–phenotype associations via Monarch for these Mondo IDs
- Animal modelNot found
No Alliance genotype “model of” associations via Monarch for these Mondo IDs
- Orphan designationNot found
No FDA or EMA orphan-drug designation matched this disease via UMLS or preferred name Source
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
None returned for this Mondo ID. That often means “not linked under this ID,” not “no clinical features.”
Animal models (Monarch / Alliance)
None returned for this Mondo ID. Empty here is not proof that no model organism work exists under another name or gene.
Monarch fetch 2026-07-29
Therapies
Designations, candidates, and chemicals
FDA OOPD and EMA orphan designations, Open Targets clinical candidates, and CTD chemical associations via MyDisease.info. These never change the interventional-trial headline.
Orphan designation (FDA · EMA)
No designation matched this disease via UMLS or preferred name on the FDA OOPD mirror or EMA orphan register. Absence here is not proof that none exists under another wording.
Open Targets candidates
No drugs or clinical candidates returned for this Mondo ID on Open Targets.
CTD chemicals (MyDisease.info)
No CTD chemical associations returned for this Mondo ID.
Literature
Is anyone studying this?
8
8 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=3967) is 59.
8 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 59 (publications denominator n=3967).
5 in the last 10 years · high confidence · 21.1th percentile (publications denominator)
Phrase hits: 8 · MeSH hits: 0
Who's working on it?
53
Distinct author names in 8 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Moser O2 papers · 2024
University Hospital RWTH Aachen, Department of Pediatric Hematology, Oncology, and Stem Cell Transplantation, Aachen, Germany. omoser@ukaachen.de.
Papers in Europe PMC - 02
- 03
- 04Attarbaschi A1 paper · 2024
St. Anna Children's Hospital. Department of Pediatric Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
Papers in Europe PMC - 05Bierings M1 paper · 2024
Princess Maxima Center/ University Hospital for Children (WKZ), Utrecht, The Netherlands.
Papers in Europe PMC - 06Bourhis JH1 paper · 2024
Département d'Hématologie, Institut Gustave Roussy, Villejuif, France.
Papers in Europe PMC - 07Burkhardt B1 paper · 2024
Pediatric Hematology, Oncology and BMT, University Hospital Münster, Münster, Germany.
Papers in Europe PMC - 08Cario G1 paper · 2024
University Medical Center Schleswig-Holstein Kiel, División of Stem Cell Transplantation and Immunotherapy, Kiel, Germany.
Papers in Europe PMC - 09Carlson K1 paper · 2024
University Children's Hospital Dept. of Women's & Children's Health, Uppsala, Sweden.
Papers in Europe PMC - 10Chasekwa B1 paper · 2014
Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 11 September 2026 · last trial check 11 September 2026
No matched interventional trials. This is true for 77.2% of diseases in the trials denominator (5501 of 7126). Here are the researchers publishing on it.
high confidence · 38.6th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Other registries (secondary)
Broader net from EU CTIS, ISRCTN, and ICTRP when available — deduped against ClinicalTrials.gov IDs already counted above. Dual-model LLM relevance gates what we keep. These rows are not added to the interventional headline.
raw 2 · after dedupe 2 · already on CT.gov 0 · kept 0 · parent 0 · uncertain 2 · dropped 0 · fetched 2026-07-30
Source notes: ictrp: Error: ICTRP public search unavailable (WHO portal is SPA-only; SOAP needs partnership). Tried: https://apps.who.int/tri
No secondary-registry studies passed dual-model relevance for this condition name (after dedupe).
Uncertain / not reviewed (2)
- isrctn·ISRCTN45104480·Recruiting·A modular, multi-part, multi-arm, open-label, phase I/II study to evaluate the safety and tolerability of GRWD5769 alone and in combination with anticancer treatments in patients with solid malignancies
skipped — LLM skipped (--skip-llm)
- isrctn·ISRCTN10096625·No longer recruiting·Immune system changes after thymectomy (removal of the thymus gland) and childhood cardiac (heart) transplant
skipped — LLM skipped (--skip-llm)
Where to find support
Condition-specific patient organisations, when Orphanet lists them, are on the disease’s Orphanet page. We also link umbrella groups that support undiagnosed and ultra-rare families.
Orphanet entry for Congenital Epstein-Barr virus infection — check Associations / patient organisations on that page.
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Congenital Epstein-Barr virus infection" OR "Antenatal EBV infection" OR "Antenatal Epstein-Barr virus infection" OR "Congenital EBV infection" OR "Mother-to-child transmission of Epstein-Barr virus infection" OR "Mother-to-child transmission of the Epstein-Barr virus infection"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Congenital Epstein-Barr virus infection" OR "Antenatal EBV infection" OR "Antenatal Epstein-Barr virus infection" OR "Congenital EBV infection" OR "Mother-to-child transmission of Epstein-Barr virus infection" OR "Mother-to-child transmission of the Epstein-Barr virus infection"
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: ok — strategies attempted: phrase; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T01:38:10.239Z